Levodopa and the progression of Parkinson's disease [4] (multiple letters)

New England Journal of Medicine

Volumn 352, Issue 13, 2005, Pages 1386-

  Walton Hadlock, Janice L ^a   Fahn, Stanley ^b   Keiburtz, Karl ^c   Tanner, Caroline M ^d  

^a Five Branches Institute   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

^d PARKINSON S INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE; LEVODOPA; PLACEBO;

CELL LOSS; DOPAMINE BRAIN LEVEL; DRUG HALF LIFE; HUMAN; LETTER; LIMBIC SYSTEM; MOTOR PERFORMANCE; ON OFF PHENOMENON; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL;

ANTIPARKINSON AGENTS; HALF-LIFE; HUMANS; LEVODOPA; LIMBIC SYSTEM; MOTOR ACTIVITY; PARKINSON DISEASE;

EID: 20144376964     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200503313521324     Document Type: Letter

References (0)